ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
TAPISTRY: Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial
Protocol ID
TAPISTRY
Condition/s
Solid Tumours
Diagnosis Stage
Relapsed/ refractory
Location
NSW, VIC
Sponsor
Hoffmann-La Roche
Links
External Registry ≫
Trial Status
Open
Sites
Sydney Children's Hospital
Royal Children's Hospital
Study Type
Treatment
Phase
Phase 2
Age Eligibility
no limits
International registry ID's
NCT04589845
Back to Registry
Study Title TAPISTRY: Tumor-Agnostic Precision Immunooncology and Somatic Targeting Rational for You (TAPISTRY) Phase II Platform Trial
Protocol ID TAPISTRY
Disease (Sub Disease) Solid Tumours
Diagnosis Stage Relapsed/ refractory
Location NSW / VIC
Sponsor Hoffmann-La Roche
Links https://clinicaltrials.gov/ct2/show/NCT04589845
Trial Status Open
Trial Open Date 18/01/2021
Sites Sydney Children's Hospital / Royal Children's Hospital
Study Type Treatment
Phase Phase 2
Age Eligibility no limits
International registry ID's NCT04589845

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168

ANZCHOG acknowledges Traditional Owners of Country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures, and to Elders both past and present. We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi. 

We are committed to creating a safe and welcoming environment that embraces all backgrounds, cultures, sexualities, genders and abilities.